Articles
| Open Access |
https://doi.org/10.55640/
SUBCLINICAL HYPOTHYROIDISM: WHEN SHOULD TREATMENT BE INITIATED?
G’ulomova Shahrinoz Qahramon kizi , Department of Fundamental Medicine, Asia International University, Bukhara, UzbekistanAbstract
Subclinical hypothyroidism (SCH) is a common endocrine disorder characterized by elevated serum thyroid-stimulating hormone (TSH) levels with normal circulating free thyroxine (fT4) concentrations. Despite its high prevalence, particularly among women and the elderly, the management of SCH remains controversial. While some patients progress to overt hypothyroidism or develop cardiovascular and metabolic complications, others remain stable or even revert to euthyroidism without intervention. Recent studies have produced conflicting results regarding the benefits of levothyroxine therapy, especially in mild forms of the disease. This review aims to summarize current knowledge on the epidemiology, pathophysiology, clinical implications, diagnostic approach, and treatment strategies of subclinical hypothyroidism, with a particular focus on identifying patients who may benefit from pharmacological intervention.
Keywords
subclinical hypothyroidism, TSH, levothyroxine, thyroid disorders, treatment indications.
References
Peeters RP, Razvi S.
Subclinical hypothyroidism.
Lancet Diabetes & Endocrinology. 2022;10(3):192–204.
Taylor PN, Razvi S, Pearce SHS, Dayan CM.
Clinical review: A review of the clinical consequences of subclinical thyroid dysfunction.
Journal of Clinical Endocrinology & Metabolism. 2020;105(12):dgaa672.
Rodondi N, Gussekloo J.
Subclinical hypothyroidism in older adults.
European Journal of Endocrinology. 2020;183(5):R185–R197.
Feller M, Moutzouri E, Bauer DC, et al.
Levothyroxine therapy for older adults with subclinical hypothyroidism.
New England Journal of Medicine. 2020;382(26):2494–2503.
Kahapola-Arachchige KM, Hadlow NC, Wardrop R, Lim EM, Walsh JP.
Age-specific TSH reference ranges and implications for diagnosis of subclinical hypothyroidism.
Clinical Endocrinology. 2021;95(1):87–96.
Gencer B, Collet TH, Virgini V, et al.
Thyroid function and cardiovascular outcomes: new insights.
European Heart Journal. 2021;42(23):2267–2275.
Duntas LH, Jonklaas J.
Levothyroxine therapy in subclinical hypothyroidism: new evidence and remaining questions.
Nature Reviews Endocrinology. 2021;17(12):725–736.
Negro R, Stagnaro-Green A.
Diagnosis and management of subclinical hypothyroidism in pregnancy.
BMJ. 2021;373:n1159.
Iodine deficiency, thyroid function and subclinical hypothyroidism.
European Thyroid Journal. 2022;11(1):e210046.
Pearce SHS, Brabant G, Duntas LH, et al.
European Thyroid Association clinical practice guideline for the management of subclinical hypothyroidism.
European Thyroid Journal. 2023;12(3):e220146
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.